"I remember reading in one of Bot's presentations that there are currently approx 3000 clinically defined derma conditions........so there's no shortage of future derma based targets we might choose to study...."
When speaking to Matt a little while ago regarding 1801, I asked whether cancer had been shown to be a possible candidate. He said it was, but indicated that due to the longer trial & approvals durations, it wouldn't be as commercially attractive for BOT (at their present size & balance sheet) to pursue this. There were obviously several other options which could have been pursued as well.
From my discussion with management and other research, my understanding is that a significant portion of the 3,000 clinically defined derma conditions you refer to are already on the company's radar as future product pipelines, for times when the size & balance sheet DOES allow us to pursue these opportunities..
- Forums
- ASX - By Stock
- Botanix Takeover
"I remember reading in one of Bot's presentations that there are...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $354.4M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.0¢ | $2.251M | 9.851M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 355473 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 598121 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 350473 | 0.220 |
9 | 692274 | 0.215 |
10 | 294379 | 0.210 |
10 | 968025 | 0.205 |
16 | 1384994 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 4444 | 1 |
0.230 | 141575 | 5 |
0.235 | 260195 | 7 |
0.240 | 867464 | 5 |
0.245 | 383650 | 9 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
22.5¢ |
  |
Change
0.005 ( 2.27 %) |
|||
Open | High | Low | Volume | ||
22.5¢ | 24.0¢ | 22.0¢ | 4728143 | ||
Last updated 15.58pm 28/03/2024 ? |
Featured News
BOT (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online